DBV Technologies SA (DBVT)
19.09
-0.36
(-1.85%)
USD |
NASDAQ |
Mar 20, 16:00
19.13
+0.04
(+0.21%)
After-Hours: 20:00
DBV Technologies Research and Development Expense (Quarterly) : 26.82M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| EDAP TMS SA | 2.438M |
| Cellectis SA | -- |
| Akari Therapeutics Plc | 0.2474M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 2.309M |